| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. (AUPH) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. AUPH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 13.04M | $214.71M | +814.6K | |
| CEO | 1.85M | $30.37M | - | |
| COO | 695.8K | $11.45M | - | |
| CFO | 626.4K | $10.31M | - | |
| VP | 557.4K | $9.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 | Milne George M Jr59 | Director | Buy | 5,000 | $10.82 | $54,100.00 | +11.1% | +5.6% | -15.0% | |
| Mar 2, 2022 | Martin Michael Robert82 | Chief Business Officer | Sell | 4,849 | $12.01 | $58,236.49 | -7.5% | -2.9% | -23.1% | |
| Mar 2, 2022 | Donley Matthew Maxwell54 | Ex VP, Intern'l Operations | Sell | 3,052 | $12.01 | $36,654.52 | -15.8% | -2.9% | -23.1% | |
| Mar 2, 2022 | Miller Joseph M50 | Chief Financial Officer | Sell | 3,060 | $12.01 | $36,750.60 | -31.6% | -2.9% | -23.1% | |
| Mar 2, 2022 | Colao Massimilano | Chief Commercial Officer | Sell | 3,205 | $12.01 | $38,492.05 | -19.2% | -2.9% | -23.1% | |
| Mar 2, 2022 | Greenleaf Peter49 | Chief Executive Officer | Sell | 9,068 | $12.01 | $108,906.68 | -21.6% | -2.9% | -23.1% | |
| Mar 2, 2022 | Solomons Neil82 | Chief Medical Officer | Sell | 4,846 | $12.01 | $58,200.46 | -5.1% | -2.9% | -23.1% | |
| Mar 2, 2022 | Huizinga Robert Bindert77 | EVP Of Research | Sell | 4,849 | $12.01 | $58,236.49 | -6.5% | -2.9% | -23.1% | |
| Jan 3, 2022 | Hagan Joseph P | Director | Sale+OE | 40,000 | $22.59 | $903,650.14 | -84.0% | -44.2% | -73.6% | |
| Dec 13, 2021 | Leversage Jill | Director | Buy | 1,600 | $20.04 | $32,064.00 | +43.2% | -49.5% | -76.1% |